| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1146/ANNUREV.MED.46.1.79 |
| P953 | full work available at URL | https://www.annualreviews.org/doi/pdf/10.1146/annurev.med.46.1.79 |
| P698 | PubMed publication ID | 7598486 |
| P2093 | author name string | C. E. Mogensen | |
| P2860 | cites work | The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 |
| Effects of ACE inhibition supplementary to beta blockers and diuretics in early diabetic nephropathy | Q28327681 | ||
| Renoprotective role of ACE inhibitors in diabetic nephropathy | Q33614282 | ||
| Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. | Q35180435 | ||
| Blood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes | Q35374070 | ||
| Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis | Q35824836 | ||
| Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? | Q40399759 | ||
| Epidemiology of microalbuminuria in diabetes and in the background population. | Q40629688 | ||
| The use of antihypertensive agents in prevention and treatment of diabetic nephropathy. | Q40629704 | ||
| Early diabetic nephropathy. Emerging treatment options | Q40725583 | ||
| Hypertension-related renal injury: a major contributor to end-stage renal disease | Q40821371 | ||
| Monitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease--reproducibility, progression, and efficacy of antihypertensive intervention. | Q40821377 | ||
| Increased glomerular filtration rate as a predictor of diabetic nephropathy--an 8-year prospective study | Q41120570 | ||
| Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells | Q42498740 | ||
| Effect of antihypertensive treatment on progression of incipient diabetic nephropathy | Q43513660 | ||
| Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? | Q43905227 | ||
| Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study | Q44209360 | ||
| Scientific and ethical consequences of disease prediction | Q45304354 | ||
| Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. | Q50547616 | ||
| Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. | Q51601011 | ||
| Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria | Q68883798 | ||
| The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group | Q70513402 | ||
| Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Microalbuminuria Collaborative Study Group, United Kingdom | Q70732297 | ||
| Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis | Q70734587 | ||
| Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy | Q72119681 | ||
| Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients | Q72133566 | ||
| Heparan sulfate expression patterns in the amyloid deposits of patients with Alzheimer's and Lewy body type dementia | Q72313018 | ||
| Prognostic value of urinary albumin excretion rate and other risk factors in elderly diabetic patients and non-diabetic control subjects surviving the first 5 years after assessment | Q72616614 | ||
| Treatment of hypertension in diabetes | Q72678727 | ||
| Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group | Q72742941 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 79-93 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Annual Review of Medicine | Q567363 |
| P1476 | title | Management of early nephropathy in diabetic patients | |
| P478 | volume | 46 |
| Q73254053 | Detection of microalbuminuria in diabetic patients by urinary dipstick |
| Q41069405 | Diabetes and hypertension: prognostic and therapeutic considerations |
| Q28184526 | Management of diabetic nephropathy |
| Q34240922 | Prevalence, risk factors and awareness of albuminuria on a Canadian First Nation: a community-based screening study |
| Q40415958 | Prevention of diabetic renal disease with special reference to microalbuminuria |
| Q71690246 | Serum total renin is increased before microalbuminuria in diabetes |
| Q41695572 | The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications |
Search more.